Back to today’s briefing

Story perspectives

NIH Cuts Funding, Endangering HIV Vaccine Research Progress

6/7/2025

35 7

Summary

Story summary

The U.S. National Institutes of Health's decision to halt funding for the Consortia for HIV/AIDS Vaccine Research Development after 2025 casts a shadow over vital HIV vaccine research. Promising trials for broadly neutralizing antibody-based vaccines now hang in the balance, leaving researchers grappling with uncertainty and the potential loss of groundbreaking advancements in the fight against HIV.

1 of 1

Story summary

The U.S. National Institutes of Health's decision to halt funding for the Consortia for HIV/AIDS Vaccine Research Development after 2025 casts a shadow over vital HIV vaccine research. Promising trials for broadly neutralizing antibody-based vaccines now hang in the balance, leaving researchers grappling with uncertainty and the potential loss of groundbreaking advancements in the fight against HIV.